U.S. Medical Diagnostics & Research Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
![Author's Avatar](https://avatar.gurufocus.com/1_big.png)
Thermo Fisher Scientific Inc (TMO) Q2 2024 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Growth Initiatives
Thermo Fisher Scientific Inc (TMO) reports robust Q2 2024 results, raises full-year guidance, and launches innovative new products. 1 day ago
![Author's Avatar](https://avatar.gurufocus.com/1_big.png)
Medpace Holdings Inc (MEDP) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Elevated Cancellations
Medpace Holdings Inc (MEDP) reports a 14.6% revenue increase and a 44.7% rise in net income for Q2 2024, despite facing higher cancellations. 3 days ago
![Author's Avatar](https://avatar.gurufocus.com/1_big.png)
Quest Diagnostics Inc (DGX) Q2 2024 Earnings Call Transcript Highlights: Strong Base Business Growth and Strategic Acquisitions
Quest Diagnostics Inc (DGX) reports robust revenue growth and outlines future strategies amidst operational challenges. 3 days ago
![Author's Avatar](https://avatar.gurufocus.com/1_big.png)
Quest Diagnostics Inc (DGX) Q2 2024 Earnings: Revenue of $2.40 Billion Beats Estimates, GAAP EPS of $2.03 Misses Estimates
Quest Diagnostics Inc (DGX) released its 8-K filing on July 23, 2024, detailing its financial performance for the second quarter of 2024. 4 days ago
![Author's Avatar](https://avatar.gurufocus.com/1_big.png)
IQVIA Holdings Inc (IQV) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Market Challenges
IQVIA Holdings Inc (IQV) reports robust financial performance with significant gains in revenue and EPS, despite facing pricing pressures and budgetary constraints from large pharma clients. 4 days ago